J3357 Insurance Policy Changes

HCPCS J3357 is officially defined as "Ustekinumab, for subcutaneous injection, 1 mg." HCPCS J3357 is referenced in 4 tracked payer policy changes from Arkansas Blue Cross Blue Shield, Texas Medicaid, and 2 other payers. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J3357 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.